Prognostic implications of longitudinal ß-zone peripapillary atrophy enlargement in myopic choroidal neovascularization
Graefe's Archive for Clinical and Experimental Ophthalmology · 10.11.2026
DOI: 10.1007/s00417-026-07595-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Graefe's Archive for Clinical and Experimental Ophthalmology, online erschienen am 10.11.2026. Verfasst von Ye Eun Han und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic o…. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Korea Health Industry Development Institute, Asan Institute for Life Sciences, Asan Medical Center, Korea Drug Development Fund.
Abstract (Originalsprache)
PURPOSE: To investigate whether longitudinal change of ß-zone peripapillary atrophy (ß-PPA) is associated with long-term outcomes in myopic choroidal neovascularization (mCNV), and to explore its relationship with longitudinal choroidal thickness change. METHODS: This retrospective longitudinal cohort study included 53 eyes with treatment-naïve subfoveal mCNV that underwent bevacizumab monotherapy and were followed for more than five years. Longitudinal changes in the ß-PPA-to-disc area ratio (ß-PPA ratio) and subfoveal choroidal thickness (sfCT) were quantified as absolute change (Δ), annualized change rate (Δ/yr), and relative change (%Δ). Associations with treatment outcomes were evaluated using regression and correlation analysis, and their relationship with choroidal thinning was explored using additionally adjusted regression and mediation analyses. RESULTS: During a mean follow-up of 86.2 ± 27.1 months, ß-PPA ratio increased (Δ, 1.72 ± 2.41) and sfCT decreased (Δ, -31.74 ± 23.14 μm). A greater Δ ß-PPA ratio was associated with a larger baseline ß-PPA ratio (P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
- Department of Medical Science, AMIST, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Seoul Shinsegae Eye Center, Uijeongbu-si, Gyeonggi-do, Republic of Korea.
- Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. anne215@gmail.com.
- Department of Medical Science, AMIST, University of Ulsan College of Medicine, Seoul, Republic of Korea. anne215@gmail.com.
Förderung
- Korea Health Industry Development Institute
- Asan Institute for Life Sciences, Asan Medical Center
- Korea Drug Development Fund
Zitieren
APA
Han, Y. E., Kim, H. J., Yang, H. S., Moon, B. G., Lee, J. Y., Kim, J. G., Yoon, Y. H., & Kim, Y. J. (2026). Prognostic implications of longitudinal ß-zone peripapillary atrophy enlargement in myopic choroidal neovascularization. Graefe's Archive for Clinical and Experimental Ophthalmology. https://doi.org/10.1007/s00417-026-07595-5
Vancouver
Han YE, Kim HJ, Yang HS, Moon BG, Lee JY, Kim JG, et al. Prognostic implications of longitudinal ß-zone peripapillary atrophy enlargement in myopic choroidal neovascularization. Graefe's Archive for Clinical and Experimental Ophthalmology. 2026. doi:10.1007/s00417-026-07595-5
BibTeX
@article{Han2026,
author = {Han, Ye Eun and Kim, Hyun Jee and Yang, Hyun Seung and Moon, Byung Gil and Lee, Joo Yong and Kim, June-Gone and Yoon, Young Hee and Kim, Yoon Jeon},
title = {Prognostic implications of longitudinal ß-zone peripapillary atrophy enlargement in myopic choroidal neovascularization},
journal = {Graefe's Archive for Clinical and Experimental Ophthalmology},
year = {2026},
doi = {10.1007/s00417-026-07595-5}
}
EUVIMED